Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Haptoglobin genotype and renal function decline in type 1 diabetes.

Costacou T, Ferrell RE, Ellis D, Orchard TJ.

Diabetes. 2009 Dec;58(12):2904-9. doi: 10.2337/db09-0874. Epub 2009 Aug 31.


Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.

Costacou T, Fried L, Ellis D, Orchard TJ.

Am J Kidney Dis. 2011 Oct;58(4):565-73. doi: 10.1053/j.ajkd.2011.05.025. Epub 2011 Aug 15.


Hemoglobin and overt nephropathy complications in type 1 diabetes.

Conway B, Fried L, Orchard T.

Ann Epidemiol. 2008 Feb;18(2):147-55.


Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.

Theilade S, Hansen TW, Goetze JP, Rossing P.

Am J Hypertens. 2015 Jun;28(6):772-9. doi: 10.1093/ajh/hpu227. Epub 2014 Dec 1.


Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.

Theilade S, Hansen TW, Rossing P.

Am J Hypertens. 2014 Sep;27(9):1152-9. doi: 10.1093/ajh/hpu030. Epub 2014 Mar 13.


Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.


A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.

Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, Postmus D, Forsblom C, Groop PH, Vionnet N, Hadjadj S, Marre M, Parving HH, Rossing P, Tarnow L.

Diabetologia. 2010 Dec;53(12):2562-8. doi: 10.1007/s00125-010-1863-0. Epub 2010 Aug 14.


Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

Rossing P, Hougaard P, Borch-Johnsen K, Parving HH.

BMJ. 1996 Sep 28;313(7060):779-84.


The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.

Groop PH, Thomas MC, Moran JL, Wadèn J, Thorn LM, Mäkinen VP, Rosengård-Bärlund M, Saraheimo M, Hietala K, Heikkilä O, Forsblom C; FinnDiane Study Group.

Diabetes. 2009 Jul;58(7):1651-8. doi: 10.2337/db08-1543. Epub 2009 Apr 28.


Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.

Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG.

JAMA. 2006 Jul 26;296(4):421-6.


Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.

Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51. doi: 10.2215/CJN.00580111. Epub 2011 Aug 18.


The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.

Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group.

Diabetes Care. 2011 Apr;34(4):861-6. doi: 10.2337/dc10-1722. Epub 2011 Feb 9.


Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway.

Gagnum V, Stene LC, Leivestad T, Joner G, Skrivarhaug T.

Diabetes Care. 2017 Jan;40(1):38-45. doi: 10.2337/dc16-1213. Epub 2016 Oct 21.


Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study.

Morimoto A, Onda Y, Nishimura R, Sano H, Utsunomiya K, Tajima N; Diabetes Epidemiology Research International Mortality Study Group.

Diabetologia. 2013 Oct;56(10):2171-5. doi: 10.1007/s00125-013-3001-2. Epub 2013 Aug 1.


Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2011 Mar;22(3):545-53. doi: 10.1681/ASN.2010040354. Epub 2011 Feb 25.


Microalbuminuria and mortality in long-duration type 1 diabetes.

Allen KV, Walker JD.

Diabetes Care. 2003 Aug;26(8):2389-91.


Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.

Costacou T, Ellis D, Fried L, Orchard TJ.

Am J Kidney Dis. 2007 Nov;50(5):721-32.


Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.

Chiarelli F, Catino M, Tumini S, de Martino M, Mezzetti A, Verrotti A, Vanelli M.

Diabetes Care. 1999 Jul;22(7):1158-64.


Mortality experience of a low-income population with young-onset diabetes.

Conway BN, May ME, Signorello LB, Blot WJ.

Diabetes Care. 2012 Mar;35(3):542-8. doi: 10.2337/dc11-1385. Epub 2012 Jan 11.

Supplemental Content

Support Center